MCID: DLS001
MIFTS: 44

Delusional Disorder

Categories: Mental diseases

Aliases & Classifications for Delusional Disorder

MalaCards integrated aliases for Delusional Disorder:

Name: Delusional Disorder 12 73 15 70 32

Classifications:



External Ids:

Disease Ontology 12 DOID:778
ICD9CM 34 297.1
MeSH 44 D012563
NCIt 50 C94379
SNOMED-CT 67 48500005
ICD10 32 F22 F22.0
UMLS 70 C0011251

Summaries for Delusional Disorder

Disease Ontology : 12 A psychotic disorder that involves an uncommon psychiatric condition in which patients present with circumscribed symptoms of non-bizarre delusions, but with the absence of prominent hallucinations and no thought disorder, mood disorder, or significant flattening effect.

MalaCards based summary : Delusional Disorder is related to paranoid schizophrenia and obsessive-compulsive personality disorder. An important gene associated with Delusional Disorder is DRD2 (Dopamine Receptor D2), and among its related pathways/superpathways are Circadian entrainment and Circadian rythm related genes. The drugs Dopamine and Olanzapine have been mentioned in the context of this disorder. Affiliated tissues include eye, ovary and pituitary, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 73 Delusional disorder is a generally rare mental illness in which a person presents delusions, but with no... more...

Related Diseases for Delusional Disorder

Diseases related to Delusional Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 172)
# Related Disease Score Top Affiliating Genes
1 paranoid schizophrenia 30.1 HTR2A HTR1A DISC1
2 obsessive-compulsive personality disorder 30.1 HTR2A DRD3
3 social phobia 30.0 PRODH HTR2A HTR1A DRD2
4 anorexia nervosa 29.9 HTR2C HTR2A HTR1A DRD4
5 depression 29.9 HTR2C HTR2A HTR1A
6 hypochondriasis 29.8 HTR2C HTR2A HTR1A
7 tardive dyskinesia 29.8 HTR2A DRD4 DRD3 DRD2 CYP2D6
8 schizophrenia 2 29.7 PRODH DISC1
9 conduct disorder 29.7 SLC6A3 DRD4 DRD2
10 hyperprolactinemia 29.7 HTR2C HTR2A DRD4 DRD2
11 substance dependence 29.6 SLC6A3 DRD4 DRD3 DRD2 CYP2D6
12 phenylketonuria 29.6 TH SLC6A3 PRODH DRD2
13 schizotypal personality disorder 29.6 PRODH HTR2A DISC1
14 dyslexia 29.5 SLC6A3 DRD4 DRD3 DRD2
15 sexual disorder 29.5 HTR2C HTR2A HTR1A CYP2D6
16 eating disorder 29.5 SLC6A3 HTR2C HTR2A DRD3 DRD2
17 borderline personality disorder 29.4 SLC6A3 HTR2C HTR2A HTR1A DRD2
18 personality disorder 29.4 TH SLC6A3 HTR2C HTR2A HTR1A DRD4
19 dysthymic disorder 29.1 SLC6A3 PRODH HTR2C HTR2A HTR1A DRD4
20 schizoaffective disorder 29.0 PRODH HTR2A HTR1A DRD3 DRD2 DISC1
21 alcohol use disorder 28.8 SLC6A3 PRODH HTR2C HTR2A HTR1A DRD3
22 schizophreniform disorder 28.6 SLC6A3 PRODH HTR2C HTR2A DRD2 DISC1
23 alcohol dependence 28.5 TH SLC6A3 HTR2C HTR2A HTR1A DRD4
24 substance abuse 28.4 SLC6A3 PRODH HTR2A HTR1A DRD4 DRD3
25 schizophrenia 28.2 TH SLC6A3 PRODH HTR2C HTR2A HTR1A
26 psychotic disorder 28.1 TH SLC6A3 PRODH HTR2C HTR2A HTR1A
27 mood disorder 28.0 TH SLC6A3 PRODH HTR2C HTR2A HTR1A
28 major depressive disorder 27.7 SLC6A3 HTR2C HTR2A HTR1A DRD4 DRD3
29 mental depression 27.7 SLC6A3 PRODH HTR2C HTR2A HTR1A DRD4
30 bipolar disorder 27.6 TH SLC6A3 PRODH HTR2C HTR2A HTR1A
31 anxiety 27.5 TH SLC6A3 PRODH HTR2C HTR2A HTR1A
32 autism 27.3 TH SLC6A3 PRODH HTR2C HTR2A HTR1A
33 capgras syndrome 11.0
34 polysubstance abuse 10.3 DRD3 DRD2
35 galactorrhea 10.2 DRD2 CYP2D6
36 paraphilia disorder 10.2 DRD4 DRD2
37 kleptomania 10.2 HTR1A DRD2
38 body dysmorphic disorder 10.2
39 avoidant personality disorder 10.2
40 severe combined immunodeficiency 10.2
41 inhibited female orgasm 10.1 HTR2A HTR1A
42 oculogyric crisis 10.1 PRODH HTR2A HTR1A
43 phobia, specific 10.1 PRODH HTR2A HTR1A
44 atypical depressive disorder 10.1 HTR2A HTR1A
45 gastroparesis 10.1 TH DRD2 CYP2D6
46 akinetopsia 10.1 HTR2A CYP2D6
47 neurotic disorder 10.1 HTR2A HTR1A
48 parkinson disease 4, autosomal dominant 10.1 TH SLC6A3
49 alcoholic psychosis 10.1 SLC6A3 HTR2A
50 amphetamine abuse 10.1 TH SLC6A3

Comorbidity relations with Delusional Disorder via Phenotypic Disease Network (PDN): (show all 11)


Acute Cystitis Alzheimer Disease
Anxiety Deficiency Anemia
Dysthymic Disorder Hypothyroidism
Major Depressive Disorder Paranoid Personality Disorder
Paranoid Schizophrenia Parkinson Disease, Late-Onset
Schizophreniform Disorder

Graphical network of the top 20 diseases related to Delusional Disorder:



Diseases related to Delusional Disorder

Symptoms & Phenotypes for Delusional Disorder

GenomeRNAi Phenotypes related to Delusional Disorder according to GeneCards Suite gene sharing:

26 (show all 16)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-126 9.58 DRD4
2 Increased shRNA abundance (Z-score > 2) GR00366-A-13 9.58 PRODH
3 Increased shRNA abundance (Z-score > 2) GR00366-A-132 9.58 DRD4
4 Increased shRNA abundance (Z-score > 2) GR00366-A-148 9.58 PRODH
5 Increased shRNA abundance (Z-score > 2) GR00366-A-161 9.58 DRD3
6 Increased shRNA abundance (Z-score > 2) GR00366-A-172 9.58 DRD4
7 Increased shRNA abundance (Z-score > 2) GR00366-A-2 9.58 PRODH
8 Increased shRNA abundance (Z-score > 2) GR00366-A-23 9.58 PRODH
9 Increased shRNA abundance (Z-score > 2) GR00366-A-33 9.58 PRODH
10 Increased shRNA abundance (Z-score > 2) GR00366-A-35 9.58 DRD3
11 Increased shRNA abundance (Z-score > 2) GR00366-A-56 9.58 DRD4
12 Increased shRNA abundance (Z-score > 2) GR00366-A-58 9.58 DRD3 DRD4 PRODH
13 Increased shRNA abundance (Z-score > 2) GR00366-A-66 9.58 PRODH
14 Increased shRNA abundance (Z-score > 2) GR00366-A-70 9.58 PRODH
15 Increased shRNA abundance (Z-score > 2) GR00366-A-9 9.58 PRODH
16 Increased shRNA abundance (Z-score > 2) GR00366-A-99 9.58 PRODH

MGI Mouse Phenotypes related to Delusional Disorder:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.7 DISC1 DRD2 DRD3 DRD4 HLA-A HTR1A
2 nervous system MP:0003631 9.36 DISC1 DRD2 DRD3 DRD4 HLA-A HTR1A

Drugs & Therapeutics for Delusional Disorder

Drugs for Delusional Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 13)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved 62-31-7, 51-61-6 681
2
Olanzapine Approved, Investigational 132539-06-1 4585 135398745
3
Risperidone Approved, Investigational 106266-06-2 5073
4
Raclopride Investigational 84225-95-6
5 Psychotropic Drugs
6 Gastrointestinal Agents
7 Dopamine Agents
8 Neurotransmitter Agents
9 Antiemetics
10 Serotonin Uptake Inhibitors
11 Antipsychotic Agents
12 Dopamine Antagonists
13
Serotonin Investigational, Nutraceutical 50-67-9 5202

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 The Minimal Effective Dose of Antipsychotic Medication in Older Patients With Schizophrenia: a PET Study. Completed NCT00716755 Risperidone/Olanzapine and PET scans
2 The Momentum Trial: The Efficacy of Using a Smartphone Application to Support Shared Decision Making Through Patient Activation in People With a Diagnosis of Schizophrenia in Outpatient Treatment Settings Active, not recruiting NCT03554655
3 Individual Placement and Support (IPS) Enhanced With Cognitive Remediation and Social Skills Training in Denmark: a Randomized Controlled Trial Active, not recruiting NCT01722344

Search NIH Clinical Center for Delusional Disorder

Genetic Tests for Delusional Disorder

Anatomical Context for Delusional Disorder

MalaCards organs/tissues related to Delusional Disorder:

40
Eye, Ovary, Pituitary

Publications for Delusional Disorder

Articles related to Delusional Disorder:

(show top 50) (show all 713)
# Title Authors PMID Year
1
Oral cenesthopathy superimposed on burning mouth syndrome treated with aripiprazole: A case report with a phenomenological overview. 61
33586237 2021
2
Improvement of Somatic Delusions with Altered Regional Cerebral Blood Flow Following Electroconvulsive Therapy in a Patient with Schizoaffective Disorder. 61
33724980 2021
3
Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients. 61
33548837 2021
4
Targeting all psychopathological dimensions in the treatment of anorexia nervosa. 61
33041048 2021
5
A systematic review of clozapine's effectiveness for primary psychotic and bipolar disorders in older adults. 61
33612141 2021
6
Activity Participation and Perceived Health Status in Patients with Severe Mental Illness: a Prospective Study. 61
33349615 2020
7
Delusional infestation: Clinical presentations, diagnosis, and management. 61
33098221 2020
8
[Psychotic disorders in ICD-11: the revisions]. 61
33287579 2020
9
[Psychiatric Disorders in the Oldest-Old]. 61
33293470 2020
10
Two Case Studies of Delusions Leading to Suicide, a Selective Review. 61
32761556 2020
11
De Clérambault's syndrome revisited: a case report of Erotomania in a male. 61
33097035 2020
12
Sleep Disturbances in Patients with Persistent Delusions: Prevalence, Clinical Associations, and Therapeutic Strategies. 61
33118525 2020
13
Folie a deux in monozygotic twins with childhood trauma: A case report. 61
32534435 2020
14
The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disorders. 61
32612207 2020
15
Clozapine for Treatment-Refractory Aggressive Behavior. 61
32918660 2020
16
Aripiprazole for the treatment of delusional disorders: A systematic review. 61
32650190 2020
17
Fahr's Syndrome Misdiagnosed As Delusional Disorder: A Case Report. 61
32952430 2020
18
Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study. 61
32649925 2020
19
[Paranoia Querulans in the First Half of the 20th Century: The Case of Elsa Asenijeff (1867-1941) and the German Psychiatric Literature of that Time]. 61
32268421 2020
20
Treating the untreatable? The biopsychosocial treatment of delusional disorder: a case study. 61
32019353 2020
21
The de Clérambault syndrome: more than just a delusional disorder? 61
32286086 2020
22
A systematic review of antipsychotic agents for primary delusional infestation. 61
32658556 2020
23
Autistic traits in first-episode psychosis: Rates and association with 1-year recovery outcomes. 61
32710521 2020
24
Addressing Delusions in Women and Men with Delusional Disorder: Key Points for Clinical Management. 61
32630566 2020
25
Delusional infestation: a prototype of psychodermatological disease. 61
31773724 2020
26
A systematic review of studies with clinician-rated scales on the pharmacological treatment of delusional disorder. 61
32097136 2020
27
[The SARS-CoV-2 Pandemic and an Attempted Suicide of a Patient with Delusional Disorder]. 61
32340051 2020
28
Challenging our beliefs about delusional disorder in late life. 61
32295673 2020
29
Moderators and mediators of antipsychotic response in delusional disorder: Further steps are needed. 61
32399397 2020
30
Othello Syndrome Secondary to Cerebral Tuberculoma: A Case Report. 61
32446418 2020
31
An Australian study of delusional disorder in late life. 61
31354123 2020
32
Olfactory Reference Syndrome: A Case Report and Screening Tool. 61
32350688 2020
33
Association Between Autistic Symptoms and Self-Stigma in Patients with Schizophrenia Spectrum Disorders. 61
33154642 2020
34
Homicidal Ideation and Forensic Psychopathology: Evidence From the 2016 Nationwide Emergency Department Sample (NEDS). 61
31404481 2020
35
Abnormal cerebellar volume in somatic vs. non-somatic delusional disorders. 61
31993210 2020
36
Aberrant Gray Matter Volume and Cortical Surface in Paranoid-Type Delusional Disorder. 61
32160619 2020
37
Isotretinoin-Induced Delusional Disorder, Somatic Subtype. 61
32774942 2020
38
[Psychosis Associated with Herbal Products: Iatrogenic Delusional Disorder]. 61
32425153 2019
39
Iatrogenic cerebral abscess leading to resolution of severe delusional disorder. 61
31796437 2019
40
Psychiatric disorders associated with acquired brain pathology. 61
30183352 2019
41
The role of serious mental illness in motivation, participation and adoption of health behavior change among obese/sedentary Latino adults. 61
29124951 2019
42
Basic self-disturbances independently predict recovery in psychotic disorders: A seven year follow-up study. 61
31420200 2019
43
A new somatic-type delusional disorder subtype: delusion inversus. 61
31735003 2019
44
First-episode psychosis and vocational outcomes: A predictive model. 61
31327504 2019
45
The characteristics and risk factors for common psychiatric disorders in patients with cancer seeking help for mental health. 61
31481035 2019
46
Smaller Pituitary Volumes in Patients with Delusional Disorder. 61
31762560 2019
47
Post-Finasteride Syndrome: An Induced Delusional Disorder with the Potential of a Mass Psychogenic Illness? 61
31559258 2019
48
Extended suicide, or homicide followed by suicide. 61
31483084 2019
49
Two Cases of Gastrointestinal Delusional Parasitosis Presenting as Folie á Deux. 61
31737714 2019
50
Shared Psychotic Disorder (Folie À Deux): A Rare Case with Dissociative Trance Disorder That Can Be Induced. 61
31777640 2019

Variations for Delusional Disorder

Expression for Delusional Disorder

Search GEO for disease gene expression data for Delusional Disorder.

Pathways for Delusional Disorder

Pathways related to Delusional Disorder according to GeneCards Suite gene sharing:

(show all 12)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.5 TH SLC6A3 DRD4 DRD3 DRD2
3
Show member pathways
11.74 TH SLC6A3 DRD2
4 11.73 HTR2C HTR2A HTR1A CYP2D6
5 11.66 HTR2A DRD4 DRD3
6 11.58 HTR2C HTR2A DRD2
7
Show member pathways
11.56 TH DRD4 DRD3 DRD2
8
Show member pathways
11.47 HTR2C HTR2A HTR1A DRD4 DRD3 DRD2
9 10.94 HTR2C HTR2A HTR1A
10 10.81 HTR2C HTR2A
11 10.63 TH HTR2C DRD2
12
Show member pathways
10.46 TH SLC6A3 HTR1A DRD4 DRD3 DRD2

GO Terms for Delusional Disorder

Cellular components related to Delusional Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 synapse GO:0045202 9.88 HTR2C HTR2A HTR1A DRD3 DRD2 DISC1
2 glutamatergic synapse GO:0098978 9.76 HTR2A DRD4 DRD3 DRD2
3 axon GO:0030424 9.72 TH SLC6A3 HTR2A DRD2 DISC1
4 integral component of plasma membrane GO:0005887 9.56 SLC6A3 HTR2C HTR2A HTR1A HLA-A DRD4
5 integral component of presynaptic membrane GO:0099056 9.54 SLC6A3 HTR2A DRD2
6 dopaminergic synapse GO:0098691 9.43 SLC6A3 DRD2
7 integral component of postsynaptic membrane GO:0099055 9.43 SLC6A3 HTR2A DRD2
8 G protein-coupled serotonin receptor complex GO:0098666 9.16 HTR2C HTR2A
9 dendrite GO:0030425 9.1 TH HTR2C HTR2A HTR1A DRD4 DRD2

Biological processes related to Delusional Disorder according to GeneCards Suite gene sharing:

(show top 50) (show all 55)
# Name GO ID Score Top Affiliating Genes
1 G protein-coupled receptor signaling pathway GO:0007186 10.19 HTR2C HTR2A HTR1A DRD4 DRD3 DRD2
2 chemical synaptic transmission GO:0007268 9.99 HTR2C HTR2A HTR1A DRD4
3 response to ethanol GO:0045471 9.91 TH SLC6A3 DRD3 DRD2
4 learning GO:0007612 9.85 TH DRD3 BCHE
5 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger GO:0007187 9.84 HTR2C HTR2A HTR1A DRD4
6 social behavior GO:0035176 9.83 TH DRD4 DRD3
7 response to cocaine GO:0042220 9.83 SLC6A3 DRD3 DRD2
8 release of sequestered calcium ion into cytosol GO:0051209 9.83 HTR2C HTR2A DRD2
9 cellular calcium ion homeostasis GO:0006874 9.83 HTR2C HTR2A DRD4 DRD3 DRD2
10 response to nicotine GO:0035094 9.79 TH SLC6A3 DRD2
11 positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway GO:0051482 9.79 HTR2C DRD3 DRD2
12 response to amphetamine GO:0001975 9.77 TH DRD4 DRD2
13 behavioral fear response GO:0001662 9.77 HTR2C HTR1A DRD4
14 regulation of dopamine secretion GO:0014059 9.76 HTR2A DRD3 DRD2
15 arachidonic acid secretion GO:0050482 9.75 DRD4 DRD3 DRD2
16 negative regulation of protein secretion GO:0050709 9.74 DRD4 DRD3 DRD2
17 dopamine metabolic process GO:0042417 9.73 DRD4 DRD3 DRD2
18 positive regulation of neuroblast proliferation GO:0002052 9.72 DRD2 DISC1
19 dopamine receptor signaling pathway GO:0007212 9.72 DRD4 DRD2
20 behavior GO:0007610 9.72 HTR2C HTR2A HTR1A
21 negative regulation of adenylate cyclase activity GO:0007194 9.71 DRD3 DRD2
22 temperature homeostasis GO:0001659 9.71 HTR2A DRD2
23 adenylate cyclase-activating adrenergic receptor signaling pathway GO:0071880 9.71 DRD3 DRD2
24 response to iron ion GO:0010039 9.71 SLC6A3 DRD2
25 negative regulation of cytosolic calcium ion concentration GO:0051481 9.7 DRD3 DRD2
26 neurotransmitter biosynthetic process GO:0042136 9.7 TH SLC6A3
27 positive regulation of renal sodium excretion GO:0035815 9.7 DRD3 DRD2
28 G protein-coupled receptor internalization GO:0002031 9.7 DRD3 DRD2
29 prepulse inhibition GO:0060134 9.7 SLC6A3 DRD3 DRD2
30 response to drug GO:0042493 9.7 TH SLC6A3 HTR2C HTR2A DRD3 DRD2
31 regulation of postsynaptic neurotransmitter receptor internalization GO:0099149 9.69 DRD4 DRD3
32 negative regulation of synaptic transmission GO:0050805 9.69 DRD2 BCHE
33 dopamine biosynthetic process GO:0042416 9.69 TH SLC6A3
34 negative regulation of voltage-gated calcium channel activity GO:1901386 9.69 DRD4 DRD3 DRD2
35 phospholipase C-activating dopamine receptor signaling pathway GO:0060158 9.68 DRD3 DRD2
36 behavioral response to ethanol GO:0048149 9.68 DRD4 DRD2
37 adenohypophysis development GO:0021984 9.68 SLC6A3 DRD2
38 serotonin receptor signaling pathway GO:0007210 9.67 HTR2A HTR1A
39 regulation of potassium ion transport GO:0043266 9.67 DRD3 DRD2
40 negative regulation of synaptic transmission, glutamatergic GO:0051967 9.67 HTR2A DRD3 DRD2
41 G protein-coupled serotonin receptor signaling pathway GO:0098664 9.67 HTR2C HTR2A HTR1A DRD4
42 regulation of dopamine uptake involved in synaptic transmission GO:0051584 9.66 DRD3 DRD2
43 regulation of locomotion involved in locomotory behavior GO:0090325 9.65 DRD3 DRD2
44 regulation of dopamine metabolic process GO:0042053 9.65 SLC6A3 HTR1A DRD4
45 locomotory behavior GO:0007626 9.65 TH SLC6A3 HTR2C DRD3 DRD2
46 positive regulation of dopamine uptake involved in synaptic transmission GO:0051586 9.64 DRD4 DRD2
47 acid secretion GO:0046717 9.64 DRD3 DRD2
48 isoquinoline alkaloid metabolic process GO:0033076 9.63 TH CYP2D6
49 positive regulation of phosphatidylinositol biosynthetic process GO:0010513 9.63 HTR2C HTR2A
50 hyaloid vascular plexus regression GO:1990384 9.63 TH SLC6A3 DRD2

Molecular functions related to Delusional Disorder according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 G protein-coupled receptor activity GO:0004930 9.93 HTR2C HTR2A HTR1A DRD4 DRD3 DRD2
2 protein-containing complex binding GO:0044877 9.78 SLC6A3 HTR2A DRD2 DISC1
3 neurotransmitter receptor activity GO:0030594 9.67 HTR2C HTR2A HTR1A DRD4
4 G protein-coupled serotonin receptor activity GO:0004993 9.56 HTR2C HTR2A HTR1A DRD4
5 serotonin binding GO:0051378 9.5 HTR2C HTR2A HTR1A
6 Gq/11-coupled serotonin receptor activity GO:0001587 9.43 HTR2C HTR2A
7 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding GO:0071886 9.4 HTR2C HTR2A
8 dopamine neurotransmitter receptor activity GO:0004952 9.33 DRD4 DRD3 DRD2
9 dopamine neurotransmitter receptor activity, coupled via Gi/Go GO:0001591 9.13 DRD4 DRD3 DRD2
10 dopamine binding GO:0035240 8.92 TH SLC6A3 DRD4 DRD2

Sources for Delusional Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....